about
Characterization and Structure of the Manganese-Responsive Transcriptional Regulator ScaR ,Bidentate Zinc Chelators for α-Carbonic Anhydrases that Produce a Trigonal Bipyramidal Coordination GeometryMetalloprotein–Inhibitor Binding: Human Carbonic Anhydrase II as a Model for Probing Metal–Ligand Interactions in a Metalloprotein Active SiteNucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors‘Unconventional’ Coordination Chemistry by Metal Chelating Fragments in a Metalloprotein Active SitePostsynthetic modification of metal-organic frameworksA novel heterocyclic atom exchange reaction with Lawesson's reagent: a one-pot synthesis of dithiomaltolEnhanced photochemical hydrogen production by a molecular diiron catalyst incorporated into a metal-organic frameworkSynthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: Developing a structure–activity relationshipTo bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibitionMetal-induced structural organization and stabilization of the metalloregulatory protein MntR.Conformational studies of the manganese transport regulator (MntR) from Bacillus subtilis using deuterium exchange mass spectrometry.Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.Synthesis and metal binding properties of salicylate-, catecholate-, and hydroxypyridinonate-functionalized dendrimers.Chelator fragment libraries for targeting metalloproteinases.From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteasesA macrophage cell model for selective metalloproteinase inhibitor designEffects of novel semiselective matrix metalloproteinase inhibitors on ex vivo cardiac structure-function.Zinc-binding groups modulate selective inhibition of MMPs.Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxideIdentifying chelators for metalloprotein inhibitors using a fragment-based approach.Moisture-resistant and superhydrophobic metal-organic frameworks obtained via postsynthetic modification.Enzymatic activation of a matrix metalloproteinase inhibitorTargeting metalloproteins by fragment-based lead discovery.Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors.Exploring the influence of the protein environment on metal-binding pharmacophores.Evaluation of heterogeneous metal-organic framework organocatalysts prepared by postsynthetic modificationHydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approachInvestigating chelating sulfonamides and their use in metalloproteinase inhibitorsCisplatin: from DNA damage to cancer chemotherapy.Readily accessible fluorescent probes for sensitive biological imaging of hydrogen peroxideAntagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase.Structural dynamics inside a functionalized metal-organic framework probed by ultrafast 2D IR spectroscopyEvaluating prodrug strategies for esterase-triggered release of alcoholsInhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity.Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release.Dual-responsive nanoparticles release cargo upon exposure to matrix metalloproteinase and reactive oxygen species.A bioinorganic perspective on matrix metalloproteinase inhibition.Discovery of an Inhibitor of the Proteasome Subunit Rpn11.
P50
Q27657622-FDE1F648-3EF5-4CC4-8F92-53DB719EB931Q27663412-D658FE0E-BD28-44FB-B65B-62B1E56FA788Q27678293-42F9A8BA-0898-4569-BEB6-0D80B9685ADBQ27678723-87AB5DD4-E16D-4959-9D87-B71670B5A811Q27682257-52273C75-9867-4F2E-81AF-B02FD83713D7Q28242072-83567DAB-1108-4B72-9950-5A5C25E0DD1AQ28288265-C69C0DB0-9395-429E-91CD-DA8FF9A8A699Q28661578-AFC46704-E8B3-4588-A318-C91FC2821745Q29012564-1C9F04F3-1868-4F8B-B73C-F12DE60808CFQ29395518-F87A8C14-A672-4B58-B56F-FDC5E80661C4Q30350282-E6BE4C6D-99F3-481E-9371-211A799172F7Q30360194-6BD76D5C-FAEC-4FD8-8BC9-E09297A03452Q31028431-B4A59B65-3145-4E6A-B098-C26190D3E6D0Q31032351-002B9D03-0F03-4765-AB32-8F7502AC37C9Q32012534-05C1F5A9-C3E6-41DD-8048-6318892B0AE5Q33522652-CF52E327-7791-4053-98D8-7E3C6083C021Q33589093-41C79108-9027-48D0-981C-B2F3E550B89DQ33680972-30FF5922-F276-4228-96DF-AB092AA2B7FCQ33715912-8A91DEC3-8970-4404-9111-B92D6368D645Q33718245-1D1B7F29-89C1-4782-A599-BE3D56CCEEEEQ33737922-D3789F95-E27E-4967-B824-3E6A6D63088FQ33781388-7A2E4A57-82AF-4B86-9664-D7B3DF98813BQ33813092-C3501A41-AC07-4AF7-8BF5-90CB9DDC96C6Q33839227-D044E561-43C3-423A-A312-DF8C88B66B5DQ33896509-536EEBBC-1531-4E4E-A20B-CDF030A11254Q33934129-8A93EB37-AC50-4E3C-8611-945F5BEED654Q34104343-F6BEBA99-D98E-474D-A3D9-1D963379A947Q34129690-FFF04B67-0E54-4ABB-85D5-2800F4DC81B9Q34192005-BE364C0F-527E-4C46-83E6-57E05EABA0FDQ34192481-F29D4DFF-2E58-4475-9B3E-683ABE61FAFFQ34348474-0D8DC0B6-3133-4CD2-8EBE-2A3A3B131AFFQ34597734-B0943D23-CFDE-41EF-8CED-8A8CAD4DBFEEQ34617941-72672E88-0BB2-4E97-A288-44F74EEC638DQ34831274-58C8ECDB-3ABB-4C58-BE78-F0F0EF5A6569Q34912678-6A2F054D-13A6-4DD8-A886-85A58450649EQ35201818-42DA1F05-5C38-41A1-A667-7033E2C720C7Q35631884-B3B75A48-74DD-48BB-A389-D3CE23B06702Q35876183-128EBB78-0A59-4F44-B6E1-DFE1180D44A7Q35972647-A14E06D8-5535-4677-B152-43BA779C5D84Q36278259-614C6B20-D5D4-4D72-BD0B-E06A23DE0EFE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Seth M Cohen
@ast
Seth M Cohen
@en
Seth M Cohen
@es
Seth M Cohen
@nl
Seth M Cohen
@sl
type
label
Seth M Cohen
@ast
Seth M Cohen
@en
Seth M Cohen
@es
Seth M Cohen
@nl
Seth M Cohen
@sl
prefLabel
Seth M Cohen
@ast
Seth M Cohen
@en
Seth M Cohen
@es
Seth M Cohen
@nl
Seth M Cohen
@sl
P106
P21
P31
P496
0000-0002-5233-2280
P569
2000-01-01T00:00:00Z